$GTBP ~ GT Biopharma recently announced the sale o
Post# of 74526
![Avatar](/images/ProfileImages/2107097394_5259_BCNstocks photo - small.jpg)
https://www.barchart.com/story/stocks/quotes/...erapeutics
Under the terms of the Asset Purchase Agreement, DAS Therapeutics acquires all rights, title, clinical data, composition-of-matter and use patents related to GTB-004. GT Biopharma will receive a $200,000 up-front payment, annual royalties of 1.5% of Net Yearly Sales, and a $6 million payment based on achievement of commercial milestone.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)